Carcinogenesis, Vol 19, 213-217, Copyright © 1998 by Oxford University Press
AS Johnson, CG Couto and CM Weghorst
Inactivation of the p53 tumor suppressor gene has been implicated in the
pathogenesis of numerous human cancers, including osteosarcomas.
Appendicular osteosarcomas of the dog appear to be a good model for their
human equivalent with regard to biologic behavior, epidemiology and
histopathology. We individually screened exons 5-8 of the p53 gene for
mutations in 15 canine appendicular osteosarcomas using 'Cold' SSCP to
compare the role of this gene in human and canine osteosarcoma
tumorigenesis. Seven of the tumors (47%) exhibited point mutations, with
one tumor possessing two mutations within different exons. Of these, seven
were missense mutations and the eighth was a 'silent' mutation potentially
affecting the exon 6-7 splicing region. Five of the missense mutations were
located in highly conserved regions IV and V, while another corresponded
with the highly conserved codon 220 mutational hotspot located outside the
conserved domains. The locations and types of mutations were nearly
identical to those reported in human cancer. These findings provide strong
evidence of the involvement of p53 mutations in the development of canine
appendicular osteosarcomas. Canine osteosarcomas appear to be a promising
model for their human equivalent on a clinical, pathologic, and molecular
level.
ARTICLES
Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog
Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus 43210-1240, USA.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Stoica, H.-T. Kim, D. G. Hall, and J. R. Coates Morphology, Immunohistochemistry, and Genetic Alterations in Dog Astrocytomas Vet. Pathol., January 1, 2004; 41(1): 10 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Loukopoulos, J. R. Thornton, and W. F. Robinson Clinical and Pathologic Relevance of p53 Index in Canine Osseous Tumors Vet. Pathol., May 1, 2003; 40(3): 237 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Levine, T. Forest, and C. Smith Tumor Suppressor PTEN is Mutated in Canine Osteosarcoma Cell Lines and Tumors Vet. Pathol., May 1, 2002; 39(3): 372 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A.W. TenHave-Opbroek, X.-B. Shi, and P. H. Gumerlock 3-Methylcholanthrene triggers the differentiation of alveolar tumor cells from canine bronchial basal cells and an altered p53 gene promotes their clonal expansion Carcinogenesis, August 1, 2000; 21(8): 1477 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Muto, S. Wakui, H. Takahashi, S. Maekawa, T. Masaoka, S. Ushigome, and M. Furusato p53 Gene Mutations Occurring in Spontaneous Benign and Malignant Mammary Tumors of the Dog Vet. Pathol., May 1, 2000; 37(3): 248 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Levine and M. A. Fleischli Inactivation of p53 and Retinoblastoma Family Pathways in Canine Osteosarcoma Cell Lines Vet. Pathol., January 1, 2000; 37(1): 54 - 61. [Abstract] [Full Text] [PDF]
|
|